Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer
Xinxing Du(Shanghai Jiao Tong University), Baijun Dong(Renji Hospital), Binbin Xia(Shanghai Jiao Tong University), Xudong Yao(Tongji University), Yanhao Dong(Massachusetts Institute of Technology), Bin Yang(Tongji University), Fan Wu(Quanzhou Normal University), Jialin Wang(Harbin Medical University), Liancheng Fan(Shanghai Jiao Tong University), Yanqing Wang(First Affiliated Hospital of Xiamen University), Hanjing Zhu(Shanghai Jiao Tong University), Yiming Gong(Chongqing University), Yinjie Zhu(Shanghai Jiao Tong University), Wei Chen(Wenzhou Medical University), Xiaochen Fei(Renji Hospital), Liang Dong(Shanghai Jiao Tong University), Jiahua Pan(University of Science and Technology of China)
Cited by 8
Related Papers
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma
|New England Journal of Medicine|2023|695
Ultra-high-voltage Ni-rich layered cathodes in practical Li metal batteries enabled by a sulfonamide-based electrolyte
|Nature Energy|2021|652
Single-cell analysis supports a luminal-neuroendocrine transdifferentiation in human prostate cancer
|Communications Biology|2020|222